Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

PLASTIC ADDITIVE 12 CRS (250 MG)

PLASTIC ADDITIVE 12 CRS (250 MG)

31570-04-4

DISCOVER
PLASTIC ADDITIVE 13 CRS (180 MG)

PLASTIC ADDITIVE 13 CRS (180 MG)

27676-62-6

DISCOVER
PLASTIC ADDITIVE 14 CRS (250 MG)

PLASTIC ADDITIVE 14 CRS (250 MG)

3806-34-6

DISCOVER
PLASTIC ADDITIVE 15 CRS (500 MG)

PLASTIC ADDITIVE 15 CRS (500 MG)

2500-88-1

DISCOVER
PLASTIC ADDITIVE 16 CRS (250 MG)

PLASTIC ADDITIVE 16 CRS (250 MG)

123-28-4

DISCOVER
PLASTIC ADDITIVE 17 CRS (250 MG)

PLASTIC ADDITIVE 17 CRS (250 MG)

693-36-7

DISCOVER
PLASTIC ADDITIVE 18 CRS (50 MG)

PLASTIC ADDITIVE 18 CRS (50 MG)

NA

DISCOVER
PLASTIC ADDITIVE 22 CRS (100 MG)

PLASTIC ADDITIVE 22 CRS (100 MG)

65447-77-0

DISCOVER
PLASTIC ADDITIVE 23 CRS (200 MG)

PLASTIC ADDITIVE 23 CRS (200 MG)

NA

DISCOVER
POLIOMYELITIS VACCINE (INACTIVATED) BRP (0.6 ML)

POLIOMYELITIS VACCINE (INACTIVATED) BRP (0.6 ML)

ND

DISCOVER
POLOXAMER 124 CRS (500 MG)

POLOXAMER 124 CRS (500 MG)

06/11/9003

DISCOVER
POLOXAMER 188 CRS (20 MG)

POLOXAMER 188 CRS (20 MG)

106392-12-5

DISCOVER